TVM Capital Healthcare has announced the first closing of its $150 million TVM Healthcare Southeast Asia Fund, aimed at addressing critical healthcare needs in the region. The fund, which is the third generation of TVM Capital Healthcare funds, will focus on high-demand but underserved areas such as post-acute care, women’s health, and local pharmaceutical manufacturing.
The fund has attracted commitments from a diverse group of institutional investors, including cornerstone investor Invest International, a Dutch government-backed entity. This initiative aims to enhance healthcare access and quality whilst promoting sustainable economic growth.
TVM Capital Healthcare plans to scale local speciality care clinics into national and regional leaders and invest in healthcare innovations from the US and Europe. The firm has established partnerships with US-based Harvard-affiliated hospitals and leading European medtech companies to accelerate the transfer of advanced medical technologies and best practices to Southeast Asia.
Hoda Abou-Jamra, Co-Founder and Managing Partner of Southeast Asia at TVM Capital Healthcare, stated, “This first close marks an important step in supporting Southeast Asia’s healthcare ecosystem and entrepreneurs.”
Partner Jannie Tsuei added, “We see a unique opportunity in Southeast Asia’s healthcare sector, particularly in specialty care and medical manufacturing.”
Eelco Benink, Head of Equity at Invest International, commented on the fund’s alignment with their mission to create sustainable impact, saying, “Together, we will help build healthcare infrastructure that benefits patients and supports long-term development.”
TVM Capital Healthcare’s strategic focus on operational partnerships and robust governance aims to elevate emerging market healthcare systems to new standards of care.
